Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 183 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

ANCA Associated Vasculitis (AAV) Phase2 Israel
Japan
Saudi Arabia
Singapore
Switzerland
United States
View All

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors Phase1, Phase2 Australia
Canada
Israel
Japan
Korea, Republic of
Singapore
United States
View All

Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.

Hidradenitis Suppurativa United Arab Emirates

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Relapsing Multiple Sclerosis (RMS) Phase3 Puerto Rico
United States

Modifying PEST for Psoriatic Arthritis Screening

Plaque Psoriasis, Psoriatic Arthritis Na Canada

LATAM LOWERS LDL-C

Hypercholesterolaemia Phase4 Argentina
Brazil

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa Phase3 Argentina
Austria
Canada
Czechia
France
Germany
Hungary
Malaysia
Poland
Puerto Rico
Romania
Spain
United States
View All

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis Phase3 Australia
United States

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Chronic Myeloid Leukemia (CML) Phase2 France

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia - Homozygous Phase3 China
Malaysia
Taiwan
Turkey
United Kingdom
United States
View All